Mark Watling
Plus aucun poste en cours
Profil
Dr. Mark Watling is Medical Director at Archimedes Pharma Ltd.
Dr. Watling was previously employed as Head-Medical Partnerships by Novo Nordisk, Inc., Medical Director by Medical Action Communications Ltd, Medical Director by Cephalon, Inc., a Principal by Til Occam Ltd., and a Principal by Quintiles, Inc.
Anciens postes connus de Mark Watling
| Sociétés | Poste | Fin |
|---|---|---|
Quintiles, Inc. (California)
 Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Corporate Officer/Principal | - |
Til Occam Ltd.
 Til Occam Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Verum Partners, Til Occam Ltd. provides outsourcing services. The company is based in Guildford, UK. Til Occam was acquired by Verum Partners on October 01, 1996 for $1.56 million. | Corporate Officer/Principal | - |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Directeur Technique/Scientifique/R&D | - |
Medical Action Communications Ltd
 Medical Action Communications Ltd Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Medical Action Communications Ltd is a British company that provides strategic marketing services to pharmaceutical companies. The company is based in Egham, UK. The company was founded by Stephen Digby Bullock. Medical Action Communications was acquired by Quintiles Transnational Corp. on June 11, 1997 for $32.21 million. | Directeur Technique/Scientifique/R&D | - |
Novo Nordisk, Inc.
 Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Quintiles, Inc. (California)
Quintiles, Inc. (California) Medical/Nursing ServicesHealth Services Quintiles, Inc. provides therapeutic services. It offers medical services, information and partnering solutions to the pharmaceutical, biotechnology and healthcare industries. The company was founded in 1982 and is headquartered in San Francisco, CA. | Health Services |
Medical Action Communications Ltd
Medical Action Communications Ltd Miscellaneous Commercial ServicesCommercial Services Part of Quintiles Transnational Corp., Medical Action Communications Ltd is a British company that provides strategic marketing services to pharmaceutical companies. The company is based in Egham, UK. The company was founded by Stephen Digby Bullock. Medical Action Communications was acquired by Quintiles Transnational Corp. on June 11, 1997 for $32.21 million. | Commercial Services |
Til Occam Ltd.
Til Occam Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Verum Partners, Til Occam Ltd. provides outsourcing services. The company is based in Guildford, UK. Til Occam was acquired by Verum Partners on October 01, 1996 for $1.56 million. | Commercial Services |
Archimedes Pharma Ltd.
 Archimedes Pharma Ltd. Pharmaceuticals: MajorHealth Technology Archimedes Pharma Ltd. operates as a holding company with interests in pharmaceuticals. The company was founded by Richard Anthony de Souza, Charles Marchetti and Michael Clark on December 9, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Novo Nordisk, Inc.
Novo Nordisk, Inc. BiotechnologyHealth Technology Novo Nordisk, Inc. operates diabetes care company. It offers biopharmaceuticals, chronic weight management, human growth hormone therapy and hemophilla management services. The firm also provides rare bleeding disorders, growth hormone related disorders, and women's health. The company was founded in 1982 and is headquartered in Plainsboro, NJ. | Health Technology |
